Paul G. Mathew, MD, DNPAS, FAAN, FAHS
Articles by Paul G. Mathew, MD, DNPAS, FAAN, FAHS

The chair and vice-chair of the Headache and Facial Pain Section of the American Academy of Neurology provided insight on projects they feel are needed to advance the care of patients with migraine-related disorders. [WATCH TIME: 4 minutes]

The chair and vice-chair of the Headache and Facial Pain Section of the American Academy of Neurology discussed some of the key research needs for migraine care going forward. [WATCH TIME: 3 minutes]

The assistant professor of neurology at Harvard Medical School discussed related areas of research regarding cranial neuralgias and the optimal time to proceed with surgery.

The assistant professor of neurology at Harvard Medical School discussed why there isn’t just a “one size fits all” approach to treating cranial neuralgias.

The assistant professor of neurology at Harvard Medical School provided thoughts on the need to increase awareness on cranial neuralgias and the importance of the diagnostic process for this condition.

The assistant professor of neurology at Harvard Medical School discussed the motivation behind uncovering more about painful cranial neuralgias and their association with posttraumatic headache.

Behavioral and Lifestyle Strategies for Migraine Management
ByPeter J. Goadsby, MD, PhD, DSc,Dawn C. Buse, PhD,Jelena Pavlovic, MD, PhD,Wade M. Cooper, DO,Paul G. Mathew, MD, DNPAS, FAAN, FAHS 
Patient Selection for Neuromodulation Devices
ByPeter J. Goadsby, MD, PhD, DSc,Dawn C. Buse, PhD,Jelena Pavlovic, MD, PhD,Wade M. Cooper, DO,Paul G. Mathew, MD, DNPAS, FAAN, FAHS 
Role of Neuromodulation for Acute Treatment of Migraine
ByPeter J. Goadsby, MD, PhD, DSc,Dawn C. Buse, PhD,Jelena Pavlovic, MD, PhD,Wade M. Cooper, DO,Paul G. Mathew, MD, DNPAS, FAAN, FAHS 
Patient Selection of Novel Therapies for Migraine Treatment
ByPeter J. Goadsby, MD, PhD, DSc,Dawn C. Buse, PhD,Jelena Pavlovic, MD, PhD,Wade M. Cooper, DO,Paul G. Mathew, MD, DNPAS, FAAN, FAHS 
Intranasal DHE in Acute Treatment of Migraine
ByPeter J. Goadsby, MD, PhD, DSc,Dawn C. Buse, PhD,Jelena Pavlovic, MD, PhD,Wade M. Cooper, DO,Paul G. Mathew, MD, DNPAS, FAAN, FAHS 
Safety of CGRP Receptor Antagonists vs 5-HT1F Agonists
ByPeter J. Goadsby, MD, PhD, DSc,Dawn C. Buse, PhD,Jelena Pavlovic, MD, PhD,Wade M. Cooper, DO,Paul G. Mathew, MD, DNPAS, FAAN, FAHS 
Use of 5-HT1F Agonists in Acute Treatment of Migraine
ByPeter J. Goadsby, MD, PhD, DSc,Dawn C. Buse, PhD,Jelena Pavlovic, MD, PhD,Wade M. Cooper, DO,Paul G. Mathew, MD, DNPAS, FAAN, FAHS 
Acute Treatment of Migraine: Progress With Novel Medications
ByPeter J. Goadsby, MD, PhD, DSc,Dawn C. Buse, PhD,Jelena Pavlovic, MD, PhD,Wade M. Cooper, DO,Paul G. Mathew, MD, DNPAS, FAAN, FAHS 
Evolution of Acute Treatment of Migraine
ByPeter J. Goadsby, MD, PhD, DSc,Dawn C. Buse, PhD,Jelena Pavlovic, MD, PhD,Wade M. Cooper, DO,Paul G. Mathew, MD, DNPAS, FAAN, FAHS 
Acute Treatment of Migraine: Traditional Therapies
ByPeter J. Goadsby, MD, PhD, DSc,Dawn C. Buse, PhD,Jelena Pavlovic, MD, PhD,Wade M. Cooper, DO,Paul G. Mathew, MD, DNPAS, FAAN, FAHS 
Unmet Needs in the Management of Migraine
ByPeter J. Goadsby, MD, PhD, DSc,Dawn C. Buse, PhD,Jelena Pavlovic, MD, PhD,Wade M. Cooper, DO,Paul G. Mathew, MD, DNPAS, FAAN, FAHS